Cosmo Pharmaceuticals Future Growth

Future criteria checks 4/6

Cosmo Pharmaceuticals is forecast to grow earnings and revenue by 18.6% and 15.1% per annum respectively. EPS is expected to grow by 18.7% per annum. Return on equity is forecast to be 22% in 3 years.

Key information

18.6%

Earnings growth rate

18.7%

EPS growth rate

Pharmaceuticals earnings growth	15.4%
Revenue growth rate	15.1%
Future return on equity	22.0%
Analyst coverage	Low
Last updated	14 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

WBAG:COPN - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	254	106	181	155	4
12/31/2025	219	84	114	113	5
12/31/2024	254	120	150	151	5
6/30/2024	185	70	98	117	N/A
3/31/2024	139	32	58	75	N/A
12/31/2023	93	-5	18	34	N/A
9/30/2023	99	3	21	35	N/A
6/30/2023	104	11	24	36	N/A
3/31/2023	103	14	25	35	N/A
12/31/2022	102	17	26	33	N/A
9/30/2022	90	26	17	24	N/A
6/30/2022	78	35	8	16	N/A
3/31/2022	72	28	6	14	N/A
12/31/2021	65	22	4	13	N/A
9/30/2021	64	6	8	16	N/A
6/30/2021	63	-11	12	19	N/A
3/31/2021	62	-9	8	16	N/A
12/31/2020	61	-8	5	13	N/A
9/30/2020	64	-7	-1	6	N/A
6/30/2020	67	-7	-8	0	N/A
3/31/2020	65	-16	-22	-9	N/A
12/31/2019	62	-24	-36	-19	N/A
9/30/2019	56	-28	-35	-17	N/A
6/30/2019	50	-31	-34	-15	N/A
3/31/2019	58	-24	-27	-12	N/A
12/31/2018	66	-18	-20	-10	N/A
9/30/2018	69	-20	-23	-10	N/A
6/30/2018	73	-23	-26	-11	N/A
3/31/2018	70	-28	N/A	-10	N/A
12/31/2017	68	-32	N/A	-9	N/A
9/30/2017	68	-18	N/A	-6	N/A
6/30/2017	69	-4	N/A	-2	N/A
3/31/2017	69	8	N/A	10	N/A
12/31/2016	68	19	N/A	22	N/A
9/30/2016	70	18	N/A	18	N/A
6/30/2016	72	16	N/A	14	N/A
3/31/2016	66	132	N/A	-13	N/A
12/31/2015	61	248	N/A	-39	N/A
9/30/2015	60	241	N/A	-13	N/A
6/30/2015	59	234	N/A	13	N/A
3/31/2015	69	154	N/A	40	N/A
12/31/2014	80	73	N/A	66	N/A
9/30/2014	76	78	N/A	43	N/A
6/30/2014	72	82	N/A	20	N/A
3/31/2014	65	75	N/A	14	N/A
12/31/2013	57	69	N/A	8	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: COPN's forecast earnings growth (18.6% per year) is above the savings rate (1.2%).

Earnings vs Market: COPN's earnings (18.6% per year) are forecast to grow faster than the Austrian market (7.3% per year).

High Growth Earnings: COPN's earnings are forecast to grow, but not significantly.

Revenue vs Market: COPN's revenue (15.1% per year) is forecast to grow faster than the Austrian market (-0.4% per year).

High Growth Revenue: COPN's revenue (15.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: COPN's Return on Equity is forecast to be high in 3 years time (22%)